Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter
Investors Specify Concerns and Propose Remedies to Enzon CEO Jeffrey Buchalter and the Board of Directors NEW YORK, Jan. 30 /PRNewswire/ -- On January 28, 2009, Knott Partners and affiliated funds, which own approximately 1.8 million shares of outstanding common stock of Enzon Pharmaceutic...Sanofi-Aventis Recognized for Workplace Efforts to Prevent Cancer
...ealth threat: American Cancer Society, American Legacy Foundation, AstraZeneca, C-Change, CIGNA, Dana-Farber Cancer Institute, Duke Medicine, Edelman, enzon Pharmaceuticals, GHI, GlaxoSmithKline, Jenner & Block, Johnson & Johnson, The Lance Armstrong Foundation, MD Anderson Cancer Center, Millenniu...Flashpoint Launches Flashlight Interactive, Names Kristen Goelz Head of New Division
...ice professional agency focused on defining a brand's flashpoints by bringing unexpected solutions to ignite a brand's growth. Clients include Cordis, enzon Pharmaceuticals, Forest Laboratories, Genentech, Indevus Pharmaceuticals, Inc., Integra, Novogyne Pharmaceuticals, and UCB. Flashlight Interactive i...Flashpoint Medica Named Agency of Year by Medical Advertising News
...lty brands. Flashpoint manages three megabrands, serving as agency of record for clients that include Genentech, Johnson & Johnson-Cordis, UCB Pharma, enzon Pharmaceuticals and Indevus Pharmaceuticals. The agency provides a full range of services, including brand development, positioning, professional and ...QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...Laboratories Inc. (Nasdaq: DSCO ) Eisai Co. Ltd. (TSE: 4523.T) Encysive Pharmaceuticals Inc. (Nasdaq: ENCY ) Enzo Biochem Inc. (NYSE: ENZ ) enzon PHARMACEUTICALS INC. (Nasdaq: ENZN ) Exelixis Inc. (Nasdaq: EXEL ) Flamel Technologies (Nasdaq: FLML ) Illumina Inc. (Nasdaq: ILMN ) Incyt...Three Organizations Receive CEO Cancer Gold Standard(TM) Accreditation
...tation from the CEO Roundtable on Cancer. They are: American Cancer Society (national headquarters), American Legacy Foundation, AstraZeneca, Edelman, enzon Pharmaceuticals, GlaxoSmithKline, Jenner & Block, Johnson & Johnson, MD Anderson Cancer Center, Novartis, OSI Pharmaceuticals, Quintiles Transnational...Pharmacopeia Announces Senior Additions to Management Team
...eia, Mr. Liebler served most recently as Senior Vice President, Strategic Planning at Questcor Pharmaceuticals and held executive-level positions with enzon Pharmaceuticals, Elan Corporation, Amarin Pharmaceuticals, and Athena Neurosciences. Mr. Liebler currently serves as Vice Chairman of the Board of Tru...Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
...nt Challenges and Future Directions . This activity, which features an interactive, expert panel discussion, is supported by an educational grant from enzon Pharmaceuticals and is certified for nurses and pharmacists. Charles A. Schiffer, MD, Professor of Medicine at Wayne State University School of...Another LNA-based RNA Inhibitor Enters Clinical Trials
...od and Drug Administration (FDA) recently accepted enzon PharmaÂceutical's Investigational New Drug (IND) ... inhibitors being developed by Santaris Pharma and enzon Pharmaceuticals through a comprehensive partnershi...iety of cancers. Under the terms of the agreement, enzon will have exclusive rights to develop and commerci...Enzon to Present Preclinical Data From PEG-SN38 and PEGylation Technology Studies at AACR Meeting
...M, PT, Poster Section 25, Poster Board 9.) About enzon enzon Pharmaceuticals, Inc. is a biopharmaceutical compa...with cancer and other life-threatening conditions. enzon has a portfolio of four marketed products, Oncaspa...Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
COPENHAGEN, April 27 /PRNewswire/ -- As a testimony to the strength of Santaris Pharma's efficient Drug Discovery Engine, the Company announced today the completion of the delivery of six cancer target drug candidates to their collaboration partner Enzon Pharmaceuticals. All six drug candidate...Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
...pha Santaris Pharma's collaboration partner enzon Pharmaceuticals announced preliminary results of t...targeting solid tumors at the AACR meeting in May. enzon expects to report the results of its phase I clini...mors with EZN2968 in the 2nd half of 2009. Further enzon has announced its intention of initiation of a pha...LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
...ted with poor prognosis and resistance to therapy. enzon is currently conducting two Phase I studies, evalu... The collaboration between Santaris Pharma and enzon Pharmaceuticals started in 2006 and by 2008 Santar...arma had delivered eight LNA based cancer drugs to enzon Pharmaceuticals of which EZN-2968 was the first. T...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...ON CORP (NASDAQ: DNDN ) DENTSPLY INTERNATIONAL INC. (NASDAQ: XRAY ) DISCOVERY LABORATORIES INC. (NASDAQ: DSCO ) ENZO BIOCHEM INC. (NYSE: ENZ ) enzon PHARMACEUTICALS INC. (NASDAQ: ENZN ) EXPRESS SCRIPTS INC. (NASDAQ: ESRX ) FLAMEL TECHNOLOGIES-ADR (NASDAQ: FLML ) GERON CORP (NASDAQ: GERN ) H...BioSpace New Jersey Career Fair Attracts Over 1,000 Bioscience Candidates
...es recruiting at the event interviewed candidates from a deep talent pool throughout the day. Sean Fitzmorris, Recruiting Manager at Bridgewater-based enzon Pharmaceuticals offered, "Enzon has attended quite a few BioSpace Career Fairs and we will continue to exhibit at these events due to the number of qu...Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
...th its rich pipeline, platforms, and product development capabilities." Mr. Buchalter currently serves as President, CEO and Chairman of the Board of enzon Pharmaceuticals, Inc. (Nasdaq: ENZN ), a biopharmaceutical company dedicated to the development and commercialization of therapeutics for cancer and ...